Shu Wang

Insider Reports History

Location
Singapore, Singapore
Signature
/s/ Shu Wang
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Shu Wang:

Company Role Class Num Shares Value Price $ Report Date Ownership
CytoMed Therapeutics Ltd 10%+ Owner Ordinary Shares, no par value per share 883,858 31 Mar 2023 Direct

Insider Reports Filed by Shu Wang

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GDTC CytoMed Therapeutics Ltd 31 Mar 2023 0 $0 3 10%+ Owner 14 Apr 2023, 16:52